HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model
Open Access
- 1 December 2012
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 1 (9) , 1537-1545
Abstract
DNA vaccines are potential tools for the induction of immune responses against both infectious disease and cancer. The dermal application of DNA vaccines is of particular interest since the epiderm...Keywords
This publication has 60 references indexed in Scilit:
- DNA vaccination against oncoantigensOncoImmunology, 2012
- CCL19 (ELC) improves TH1‐polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination modelThe Journal of Gene Medicine, 2012
- CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor modelCancer Gene Therapy, 2011
- TLR-based immune adjuvantsVaccine, 2011
- The dendritic cell–tumor cross-talk in cancerCurrent Opinion in Immunology, 2011
- Combined Clinical Trial Results of a HER2/neu(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02Clinical Cancer Research, 2008
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- Current status and future prospects of needle-free liquid jet injectorsNature Reviews Drug Discovery, 2006
- Nonviral Jet-Injection Gene Transfer for Efficient in Vivo Cytosine Deaminase Suicide Gene Therapy of Colon CarcinomaMolecular Therapy, 2005
- CD4+ T cell‐mediated HER‐2/neu‐specific tumor rejection in the absence of B cellsInternational Journal of Cancer, 2003